These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6103936)

  • 1. Rotational behaviour elicited by 5-HT in the rat: evidence for an inhibitory role of 5-HT in the substantia nigra and corpus striatum.
    James TA; Starr MS
    J Pharm Pharmacol; 1980 Mar; 32(3):196-200. PubMed ID: 6103936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circling behavior induced by microinjection of serotonin reuptake inhibitors in the substantia nigra.
    Bata-García JL; Heredia-López FJ; Alvarez-Cervera FJ; Arankowsky-Sandoval G; Góngora-Alfaro JL
    Pharmacol Biochem Behav; 2002; 71(1-2):353-63. PubMed ID: 11812544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A two-population model of rat rotational behavior: effects of unilateral nigrostriatal 6-hydroxydopamine on striatal neurochemistry and amphetamine-induced rotation.
    Shapiro RM; Glick SD; Camarota NA
    Brain Res; 1987 Nov; 426(2):323-31. PubMed ID: 2446711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin--dopamine interactions in the nigrostriatal system.
    Waldmeier PC; Delini-Stula AA
    Eur J Pharmacol; 1979 May; 55(4):363-73. PubMed ID: 572774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of substance P injected into the substantia nigra.
    James TA; Starr MS
    Br J Pharmacol; 1979 Mar; 65(3):423-9. PubMed ID: 427315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ascorbate blocks amphetamine-induced turning behavior in rats with unilateral nigro-striatal lesions.
    Tolbert LC; Thomas TN; Middaugh LD; Zemp JW
    Brain Res Bull; 1979; 4(1):43-8. PubMed ID: 572739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substantia nigra as an out-put station for striatal dopaminergic responses: role of a GABA-mediated inhibition of pars reticulata neurons.
    Di Chiara G; Porceddu ML; Morelli M; Mulas ML; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Mar; 306(2):153-9. PubMed ID: 571967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of dopamine uptake blocking agents on the amphetamine-induced circling behavior in mice with unilateral nigro-striatal lesions.
    Fung YK; Uretsky NJ
    J Pharmacol Exp Ther; 1980 Sep; 214(3):651-6. PubMed ID: 6772760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circling behaviour induced by dopamine releasers and/or uptake inhibitors during degeneration of the nigrostriatal pathway.
    Oberlander C; Euvrard C; Dumont C; Boissier JR
    Eur J Pharmacol; 1979 Dec; 60(2-3):163-70. PubMed ID: 575095
    [No Abstract]   [Full Text] [Related]  

  • 10. Amphetamine-induced circling behavior in rats: effects of unilateral microinjections of GABA and GABA-related drugs into substantia nigra.
    Thiébot MH; Soubrié P
    Brain Res; 1979 May; 167(2):307-22. PubMed ID: 571751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioural effects mediated by unilateral nigral dopamine receptor stimulation in the rat.
    Kelly E; Jenner P; Marsden CD
    Exp Brain Res; 1984; 55(2):243-52. PubMed ID: 6611272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system.
    Pycock C; Milson J; Tarsy D; Marsden CD
    Neuropharmacology; 1978 Mar; 17(3):175-83. PubMed ID: 565479
    [No Abstract]   [Full Text] [Related]  

  • 13. Unilateral 5,7-dihydroxytryptamine lesions of the dorsal raphe nucleus (DRN) and rat rotational behaviour.
    Blackburn TP; Foster GA; Heapy CG; Kemp JD
    Eur J Pharmacol; 1980 Oct; 67(4):427-38. PubMed ID: 7449825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine mediates ipsi- and contraversive circling elicited from the substantia nigra.
    Vaccarino FJ; Franklin KB
    Pharmacol Biochem Behav; 1982 Sep; 17(3):431-4. PubMed ID: 6890683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan).
    Costall B; Naylor RJ
    Psychopharmacologia; 1975 Jul; 43(1):53-61. PubMed ID: 1099605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nigral dopaminergic mechanisms in drug-induced circling.
    Jackson EA; Kelly PH
    Brain Res Bull; 1983 Nov; 11(5):605-11. PubMed ID: 6607768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Stereotyped behavior and the nigro-strio-nigral system].
    Arushanian EB
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1985; 35(5):819-32. PubMed ID: 2866641
    [No Abstract]   [Full Text] [Related]  

  • 18. The roles of noradrenaline and dopamine in contraversive circling behaviour seen after unilateral electrolytic lesions of the locus coeruleus.
    Donaldson I; Dolphin A; Jenner P; Marsden CD; Pycock C
    Eur J Pharmacol; 1976 Oct; 39(2):179-91. PubMed ID: 976315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiparkinsonian drugs and dopaminergic neostriatal mechanisms: studies in rats with unilateral 6-hydroxydopamine (=6-OH-DA)-induced degeneration of the nigro-neostriatal DA pathway and quantitative recording of rotational behaviour.
    Fuxe K; Ungerstedt U
    Pharmacol Ther B; 1976; 2(1):41-7. PubMed ID: 817332
    [No Abstract]   [Full Text] [Related]  

  • 20. Opposite locomotor asymmetries elicited from the medial and lateral substantia nigra: role of the superior colliculus.
    Vaccarino FJ; Franklin KB; Prupas D
    Physiol Behav; 1985 Nov; 35(5):741-7. PubMed ID: 4080836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.